Ricoh 3D, SimBioSys to Collaborate on Precision Surgery

Ricoh USA, Inc. (Ricoh) and SimBioSys, Inc. (SimBioSys) has announced a collaborative initiative to explore technologies with potential to aid treatment of breast cancer. This collaboration aims to evaluate the potential of artificial intelligence (AI) with advanced 3D printing to help improve surgical experiences and personalize patient care for breast cancer, according to the companies.

SimBioSys, known for its TumorSight technology, a digital precision medicine platform, and Ricoh, via its Ricoh 3D for Healthcare business (Ricoh 3D for Healthcare), a leader in the manufacturing of patient-specific medical devices, plan to showcase the potential of their combined technologies. The vision for this collaboration is to help create an approach to breast cancer treatment, integrating SimBioSys’ AI capabilities with Ricoh’s 3D-printing expertise to produce accurate, patient-specific breast cancer models.

“Through a collaboration with SimBioSys, we hope to not just envision a new future for medical treatment but help actively create it," said Gary Turner, Managing Director at Ricoh USA, Inc. "Our dedication to precision and personalization in breast cancer care is about to be showcased at ASBrS, reflecting the potential of our combined efforts."

Sources: Press materials received from the company and additional information gleaned from the company’s website.